In recent years, the nutrition and health supplement market in Southeast Asia has grown rapidly. Demand for supplement tablets in countries such as Vietnam, Thailand, and Indonesia continues to rise. Facing massive consumer potential and complex regulatory diversity, many health brands share the same challenge — how to enter their target markets quickly, compliantly, and with minimal risk.

Against this backdrop, B&H leveraged its professional expertise in health supplement OEM export and complex tablet formulation to help a cross-border client complete product development, registration, and its first export launch to Southeast Asia within just six months — achieving an efficient transformation from “concept product” to “market reality.”

Southeast Asia: Rapid Growth Meets Stringent Regulation
According to GlobalData, the Southeast Asian nutritional supplement market is growing at an average annual rate of 9.2%, with multivitamins and B-complex tablets among the most popular products. Consumers increasingly prioritize functions such as “immune support,” “energy enhancement,” and “anti-fatigue,” trends closely linked to post-pandemic health awareness.
However, each country’s regulatory requirements vary greatly. Malaysia and Singapore require imported supplements to be registered with full ingredient documentation and stability testing reports, while Indonesia enforces strict labeling and packaging language standards. For brands new to export, these differences often translate into high costs and lengthy approval timelines.

B&H’s OEM Solution: From Formulation to Export Registration
In this project, B&H provided a one-stop OEM manufacturing solution, covering four key stages: formulation design, packaging development, regulatory consulting, and international logistics.

1. Scientific Formulation Development
B&H’s R&D center optimized the supplement tablet formula based on Southeast Asian dietary habits and tropical climate conditions. The formulation increased the proportion of vitamins B1, B6, B12, and coenzyme Q10, ensuring product stability and consistent taste even under high temperature and humidity.

2. Regulatory Registration Support
The B&H regulatory team offered ingredient compliance analysis and documentation preparation for Indonesia and Malaysia, including COA, MSDS, and GMP certificates. This proactive approach helped clients mitigate regulatory risks early and shorten registration timelines by nearly 40%.

3. OEM Manufacturing and Quality Control
The supplement tablets were produced in B&H’s GMP-certified facility, covering key processes such as tableting, coating, and stability testing. B&H’s production system has passed NSF and ISO22000 certifications, ensuring products meet regulatory standards from agencies such as BPOM (Indonesia) and HSA (Singapore).

4. Export and Logistics Solutions
B&H partnered with Shenzhen international logistics providers to design an integrated airfreight + customs clearance solution, ensuring safe and efficient delivery of supplement tablets to distributors across Southeast Asia.

Results: From R&D to Retail in Just Six Months
Thanks to B&H’s professional coordination, the client’s first B-complex supplement tablet was successfully launched in Jakarta, Indonesia in June 2025. Within three months, over 100,000 bottles were sold, receiving excellent feedback from major pharmacy chains and e-commerce platforms such as Tokopedia and Shopee.

More importantly, this OEM project helped the client establish a replicable market-entry model for Southeast Asia, paving the way for future product lines, including softgels and powdered supplements.

From “Manufacturing Power” to “Export Intelligence”
Industry experts note that B&H’s success lies not only in its advanced OEM manufacturing technology but also in its systematic understanding of target market regulations, consumer behavior, and supply chain efficiency.

Amid increasingly stringent international standards, B&H adheres to the philosophy of “R&D first, regulatory alignment, export without barriers”, helping clients reduce trade risks from the source and achieve truly compliant global manufacturing.

Empowering Chinese Formulations to Reach the World
As the Southeast Asian health supplement market continues to expand, more Chinese brands are entering through OEM collaboration models. With strong capabilities in tablet formulation, regulatory compliance, and international logistics, B&H is emerging as a benchmark enterprise in China’s health supplement export industry.

Looking ahead, B&H will continue to follow its strategic pillars of safety, innovation, and internationalization, empowering more brands to evolve from Made in China to Intelligently Created in China—and confidently compete in the global nutrition market.